Bacterial resistance in urinary tract infections: how to stem the tide (Q34241037)

31 July 2017

1 reference

title

Bacterial resistance in urinary tract infections: how to stem the tide (English)

1 reference

31 July 2017

urinary tract infection

1 reference

Fluit AC

1

1 reference

PubMed ID

11336624

31 July 2017

Schmitz FJ

series ordinal

2

1 reference

PubMed ID

11336624

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

813-818

1 reference

31 July 2017

5

1 reference

Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

Increasing prevalence of antimicrobial resistance among uropathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

A Dutch approach to methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

Fitness of antibiotic-resistant microorganisms and compensatory mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.5.813

21 January 2018

Identifiers

DOI

10.1517/14656566.2.5.813

1 reference

31 July 2017

1 reference

PubMed ID

11336624